These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 182179)

  • 1. Mode of action of isoniazide (INH). Short communication: isolation and identification of an analog of NAD from 3H-INH-treated bacterial cells.
    Seydel JK; Tono-oka S; Schaper KJ; Bock L; Wiencke M
    Arzneimittelforschung; 1976 Apr; 26(4):477-8. PubMed ID: 182179
    [No Abstract]   [Full Text] [Related]  

  • 2. [NAD(P)-glycohydrolase in tuberculosis bacteria. A contribution to the mechanism of action INH].
    Bartmann K; Coper H; Jütte R
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):8. PubMed ID: 4385332
    [No Abstract]   [Full Text] [Related]  

  • 3. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
    Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
    J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The mechanism of action of isoniazid. A chemical model of activation].
    Bernadou J; Nguyen M; Meunier B
    Ann Pharm Fr; 2001 Sep; 59(5):331-7. PubMed ID: 11787427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophil peroxidase oxidizes isoniazid to form the active metabolite against M. tuberculosis, isoniazid-NAD
    Babu D; Morgan AG; Reiz B; Whittal RM; Almas S; Lacy P; Siraki AG
    Chem Biol Interact; 2019 May; 305():48-53. PubMed ID: 30922765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of isoniazid.
    Timmins GS; Deretic V
    Mol Microbiol; 2006 Dec; 62(5):1220-7. PubMed ID: 17074073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H and 13C NMR characterization of pyridinium-type isoniazid-NAD adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis.
    Broussy S; Bernardes-Génisson V; Coppel Y; Quémard A; Bernadou J; Meunier B
    Org Biomol Chem; 2005 Feb; 3(4):670-3. PubMed ID: 15703806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.
    Vilchèze C; Wang F; Arai M; Hazbón MH; Colangeli R; Kremer L; Weisbrod TR; Alland D; Sacchettini JC; Jacobs WR
    Nat Med; 2006 Sep; 12(9):1027-9. PubMed ID: 16906155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
    Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating isoniazid resistance using molecular modeling.
    Wahab HA; Choong YS; Ibrahim P; Sadikun A; Scior T
    J Chem Inf Model; 2009 Jan; 49(1):97-107. PubMed ID: 19067649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of isoniazid on growth inhibition and competition for an oxidized nicotinamide adenine dinucleotide regulatory site on the electron transport pathway in Mycobacterium phlei.
    Davis WB; Weber MM
    Antimicrob Agents Chemother; 1977 Aug; 12(2):213-8. PubMed ID: 197885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between nicotinamide adenine dinucleotide concentration and antibacterial activity of isoniazid in Mycobacterium tuberculosis.
    Jackett PS; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Apr; 115(4):601-7. PubMed ID: 192114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the action of isoniazid.
    Youatt J
    Am Rev Respir Dis; 1969 May; 99(5):729-49. PubMed ID: 4306211
    [No Abstract]   [Full Text] [Related]  

  • 15. Isoniazid & nicotinamide adenine dinucleotide synthesis in Mycobacterium tuberculosis.
    Sriprakash KS; Ramakrishnan T
    Indian J Biochem; 1969 Mar; 6(1):49-50. PubMed ID: 4332124
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metabolic behavior of Mycobacterium tuberculosis strain H37 Ra under action of rifampicin, comparison with isoniazid].
    Le Cam M; Madec Y; Bernard S
    Ann Inst Pasteur (Paris); 1971 Feb; 120(2):186-95. PubMed ID: 4396428
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimycobacterial activity of isoniazid + prothionamide + dapsone against a number of randomly selected 'wild' strains of Mycobacterium tuberculosis.
    Urbanczik R
    Chemotherapy; 1980; 26(4):276-81. PubMed ID: 6771106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1H and 13C NMR characterization of hemiamidal isoniazid-NAD(H) adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis.
    Broussy S; Coppel Y; Nguyen M; Bernadou J; Meunier B
    Chemistry; 2003 May; 9(9):2034-8. PubMed ID: 12740851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant.
    Zhao X; Yu H; Yu S; Wang F; Sacchettini JC; Magliozzo RS
    Biochemistry; 2006 Apr; 45(13):4131-40. PubMed ID: 16566587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
    Hearn MJ; Cynamon MH
    Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.